ARGONAUT TECHNOLOGIES, INC. AMENDMENT TO CHANGE OF CONTROL SEVERANCE AGREEMENTChange of Control Severance Agreement • March 22nd, 2005 • Argonaut Technologies Inc • In vitro & in vivo diagnostic substances
This Amendment to the Amended and Restated Change of Control Severance Agreement (the “Agreement”) is made and entered into effective as of March 17, 2005 (the “Effective Date”), by and between Jeff Labadie (the “Employee”) and Argonaut Technologies, Inc., a Delaware corporation (the “Company”).
ARGONAUT TECHNOLOGIES, INC. AMENDMENT TO CHANGE OF CONTROL SEVERANCE AGREEMENTChange of Control Severance Agreement • March 22nd, 2005 • Argonaut Technologies Inc • In vitro & in vivo diagnostic substances
This Amendment to the Amended and Restated Change of Control Severance Agreement (the “Agreement”) is made and entered into effective as of March 17, 2005 (the “Effective Date”), by and between Gordon Tredger (the “Employee”) and Argonaut Technologies, Inc., a Delaware corporation (the “Company”).
ARGONAUT TECHNOLOGIES, INC. AMENDMENT TO CHANGE OF CONTROL SEVERANCE AGREEMENTChange of Control Severance Agreement • March 22nd, 2005 • Argonaut Technologies Inc • In vitro & in vivo diagnostic substances
This Amendment to the Amended and Restated Change of Control Severance Agreement (the “Agreement”) is made and entered into effective as of March 17, 2005 (the “Effective Date”), by and between David Foster (the “Employee”) and Argonaut Technologies, Inc., a Delaware corporation (the “Company”).
